Home › NDC Lookup › Ingredients › Clotrimazole › 24909-0050-28
femmesil Ultra Therapy Clotrimazole 1 g/100g Ointment, 28 g — NDC 24909-0050-28 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

femmesil Ultra Therapy Clotrimazole 1 g/100g Ointment, 28 g — NDC 24909-050-28 (Billing 24909-0050-28)

by Aidance Scientific, Inc. · 28 g in 1 TUBE

This is a package of 28 g of femmesil Ultra Therapy Clotrimazole 1 g/100g Ointment from Aidance Scientific, Inc., marketed since Aug 2025 and currently FDA-listed. It is this product's only package size.

NDC 24909-0050-28
🏷️ FDA NDC (as labeled) 24909-050-28 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 24909-050-28 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
24909 labeler · 050 product · 28 package
Package marketed since
Aug 25, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 2490905028 8
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Clotrimazole (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0210-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0211-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 24909-050-28
Product NDC 24909-050
11-digit billing NDC 24909005028
RxCUI 2722226
UNII G07GZ97H65
Application # M005
SPL Set ID 3d36794a-07d0-860c-e063-6294a90a6e8f
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-08-25
Route TOPICAL
Dosage form OINTMENT
Substance CLOTRIMAZOLE
Quick answers
  • RxCUI (RxNorm): 2722226
Why two NDCs? The FDA registers this code as 24909-050-28 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24909-0050-28. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole and triazole derivatives, Imidazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Skin products treat athlete's foot, jock itch and ringworm. Vaginal creams treat vaginal yeast infections, and CLOTIC ear solution treats fun...
  • Wash and dry the area, then apply a thin layer twice a day, morning and night. Most labels say about 4 weeks for athlete's foot and ringworm and 2 weeks for jock itch. See a doctor...
  • The skin products listed here say they are not effective on the scalp or nails. If the infection is there, check with your doctor.
  • With CLOTIC ear solution, the reported ones were headache, pain where it goes in, ringing in the ear and tingling. Vaginal cream can briefly increase burning or itching. Call your...
📖 Read our full Clotrimazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
24909-0050-28 You're viewing this Main listing 28 g in 1 TUBE 2025-08-25 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Clotrimazole Antifungal Cream 1 g/100g 00536-1265-26 Rugby 1 tube $0.047 — Availability likely —
Clotrimazole 1 g/100g 70000-0667-01 Cardinal 1 tube $0.063 — Availability likely —
clotrimazole 1 g/100g 45802-0434-01 Padagis 1 tube $0.146 — Discontinued —
Clotrimazole 1 g/100g 51672-2002-01 Sun 1 tube $0.219 — Availability likely —
femmesil Ultra Therapy 1 g/100gthis 24909-0050-28 Aidance 28 g — — FDA listed —
Terrasil Jock Itch Treatment Maximum Strength 1 g/100g 24909-0214-14 Aidance 14 g — — FDA listed —
TheraPlus Plus 1 g/100g 55621-0003-01 Zhejiang 35 g — — FDA listed —
Clotrimazole 1 g/100g 71205-0434-05 Proficient 1 tube — — FDA listed —
Tagrid Antifungal Jock Itch Cream Non-Steroidal Clotrimazole 1% 1 g/100g 85384-0021-01 TAGRID 60 g — — FDA listed —
Terrasil JockItch Treatment Maximum Strength 1 g/100g 24909-0212-50 Aidance 50 g — — FDA listed —
CVS Antifungal Ringworm 1 g/100g 59779-0514-01 CVS 1 tube — — FDA listed —
Antifungal 1 g/100g 84722-3059-00 VIVE 1 g — — FDA listed —
Tagrid Balanitis Relief 1 g/100g 85384-0018-01 TAGRID 30 g — — FDA listed —
Clotrimazole 1 g/100g 68788-8830-02 Preferred 1 tube — — FDA listed —
Rite Aid antifungal ringworm 1 g/100g 11822-1110-01 Rite 1 tube — — FDA listed —
Terrasil Tinea Treatment MAX 1 g/100g 24909-0104-14 Aidance 14 g — — Discontinued —
Femmesil 1 g/100g 24909-0203-25 Aidance 1 bottle — — Discontinued —
clotrimazole 1 g/100g 63187-0559-15 Proficient 1 tube — — FDA listed —
Tagrid Antifungal Ringworm Treatment 1% CLOTRIMAZOLE 1 g/100g 85384-0006-01 TAGRID 100 g — — FDA listed —
Tagrid Intertrigo Cream For Skin Fold Rash Clotrimazole 1% 1 g/100g 85384-0022-01 TAGRID 56.7 g — — FDA listed —
clotrimazole 1 g/100g 50090-0562-00 A-S 1 tube — — FDA listed —
clotrimazole 1 g/100g 68071-4225-05 NuCare 15 g — — FDA listed —
Clotrimazole 1% 1 g/100g 83324-0041-01 Chain 1 tube — — FDA listed —
ElixirCurozole 1 g/100g 84546-0003-01 ELIXIR 1 tube — — FDA listed —
Rugby Clotrimazole Antifungal Cream 1 g/100g 68788-8901-02 Preferred 1 tube — — FDA listed —
Clotrimazole 1 g/100g 50090-4971-00 A-S 1 tube — — FDA listed —
Hua Tuo Xian Gao Antifungal 1 g/100g 55614-0650-01 MADISON 1 tube — — FDA listed —
PerfectHeal Antifungal 1 g/100g 69070-0303-01 Zhejiang 1 tube — — FDA listed —
Clotrimazole 1 g/100g 69396-0001-04 TRIFECTA 1 tube — — FDA listed —
Clotrimazole 1 g/100g 69396-0087-01 TRIFECTA 1 tube — — FDA listed —
Athletes Foot Cream 1 g/100g 87739-0001-01 Shenzhen 28 g — — FDA listed —
terrasil Antifungal Cleansing Bar 1 g/100g 24909-0037-75 Aidance 75 g — — FDA listed —
Clotrimazole 1 g/100g 63187-0501-15 Proficient 1 tube — — FDA listed —
Clotrimazole 1 g/100g 68788-8216-03 Preferred 1 tube — — FDA listed —
Tagrid Antifungal Clotrimazole 1% 1 g/100g 85384-0019-01 TAGRID 100 g — — FDA listed —
Tagrid Feminine Itch Relief Cream Antifungal Formula Clotrimazole 1% 1 g/100g 85384-0023-01 TAGRID 56.7 g — — FDA listed —
terrasil Folliculitis Cream Maximum Strength 1 g/100g 24909-0064-50 Aidance 50 g — — FDA listed —
Terrasil Ringworm Treatment MAX 1 g/100g 24909-0102-14 Aidance 14 g — — Discontinued —
Terrasil Anti-Fungal Treatment MAX 1 g/100g 24909-0106-14 Aidance 14 g — — Discontinued —
Antifungal 1 g/100g 67777-0727-02 Dynarex 72 tubes — — FDA listed —
Clotrimazole 1 g/100g 50090-6546-00 A-S 1 tube — — FDA listed —
clotrimazole 1 g/100g 68071-3395-03 NuCare 30 g — — FDA listed —
Trimazole 1 g/100g 73352-0570-01 Trifluent 1 tube — — FDA listed —
Kerova ANTIFUNGAL 1 g/100g 85959-0002-01 Guangzhou 100 g — — FDA listed —
Terrasil Athletes Foot AntiFungal Treatment Max 1 g/100g 24909-0207-25 Aidance 25 g — — Discontinued —
clotrimazole 1 g/100g 50090-1770-00 A-S 1 tube — — FDA listed —
Cura Hongo Antifungal 1 g/100g 55758-0102-02 Pharmadel 1 tube — — Discontinued —
Tea Tree Antifungal 1 g/100g 87800-0001-01 HONG 100 g — — FDA listed —
Morovan Ringworm Treatment 1 g/100g 87800-0005-01 HONG 60 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Aug 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Clotrimazole inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2ZA36H0S2V
    Beeswax is a natural wax produced by honeybees. In medicines, it works as a coating agent and thickener to control how fast the drug dissolves and improve the product's texture and appearance.
  • UNII Q9L0O73W7L
    Coconut oil is a natural fat extracted from coconut fruit. It's used in medicines as a lubricant, emollient, or carrier to help dissolve or deliver active ingredients smoothly through the formulation.
  • UNII H3E878020N
    Cottonseed oil is a natural vegetable oil extracted from cotton plant seeds. It is used in medicines as a solvent and lubricant to help dissolve active ingredients and allow smooth tablet or capsule movement through manufacturing equipment.
  • UNII 724GKU717M
    Jojoba oil is a natural liquid wax extracted from jojoba plant seeds. It's used in medicines as an emollient and lubricant to soften and smooth the product, and sometimes as a carrier or penetration enhancer.
  • UNII 3A3U0GI71G
    Magnesium oxide is a mineral compound that acts as a buffer and filler in medications. It helps neutralize stomach acid and adds bulk to the tablet or capsule formulation.
  • UNII 5QUO05548Z
    Palm oil is a natural plant-based fat extracted from palm fruit. It's used as a lubricant, binder, or coating agent to help the medicine hold together, flow smoothly during manufacturing, and sometimes improve how the body absorbs the active ingredient.
  • UNII AV092KU4JH
    A natural oil extracted from peppermint plants. It's used as a flavoring agent to mask bitter tastes and add a refreshing mint flavor to medicines, making them easier to take.
  • UNII 4H6PCL92ZN
    Silver stearate is a metallic salt made from silver and stearic acid, a fatty substance. It works as a lubricant and glidant in tablet formulations, helping the medicine powder flow smoothly during manufacturing and preventing sticking.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII VIF565UC2G
    Tea tree oil is an essential oil extracted from the leaves of the Australian tea tree plant. In medicines, it typically serves as a flavoring agent, fragrance, or antimicrobial component in topical formulations.
  • UNII SOI2LOH54Z
    Zinc oxide is a white mineral powder used in medicines as a protective barrier agent and color additive. It helps shield skin in topical products and may also serve as a filler or opacifying ingredient.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbeeswax, coconut oil (organic), cottonseed oil*, jojoba oil, magnesium oxide, MCT oil, peppermint oil, silver stearate, tea tree oil, vegetable stearic acid (naturally sourced)*, zinc oxide *may contain this ingredient

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAidance Scientific, Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code24909
First marketedAug 2025
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Aidance Scientific, Inc. labeler code 24909

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 5 words ▾

Uses Treats vaginal yeast infections.

⏱️ Dosage and Administration 52 words ▾

Directions Children under 12: Ask a physician. Adults and children 12 years and older: femmesil may be used topically (outside the vaginal area) or intravaginally. Squeeze a small amount of ointment onto fingertip. Apply 2 to 3 times daily for up to 3 days or longer as needed. Store at room temperature.

⚠️ Warnings ~1 min read ▾

Warnings For vaginal use only. Do not use if you have never had a vaginal yeast infection diagnosed by a doctor; if you have a fever (higher than 100° F), pain in the lower abdomen, back, either shoulder, or a foul-smelling vaginal discharge.You should see a doctor for treatment of these symptoms. Ask a doctor before use if you have • Vaginal itching and discomfort for the first time, lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge.

You may have a more serious condition. • Vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. • Been exposed to the human immunodeficiency virus (HIV) that causes AIDS. When using this product • Do not use tampons, douches, spermicides, or other vaginal products.

Condoms or diaphragms may be damaged and fail to prevent sexually transmitted disease or pregnancy. • Do not have vaginal intercourse. • Mild increase in vaginal burning, itching, or irritation may occur. Stop use and ask a doctor if symptoms do not improve in 3 days; symptoms last more than 7 days; you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting or a foul-smelling vaginal discharge. If pregnant or breastfeeding , ask a health professional before use.

Keep out of reach of children. If swallowed, call poison control or seek medical help.

🧪 Active Ingredient 3 words ▾

Active Ingredient Clotrimazole

🧪 Inactive Ingredients 32 words ▾

Inactive Ingredients beeswax, coconut oil (organic), cottonseed oil*, jojoba oil, magnesium oxide, MCT oil, peppermint oil, silver stearate, tea tree oil, vegetable stearic acid (naturally sourced)*, zinc oxide *may contain this ingredient

🎯 Purpose 3 words ▾

Purpose Vaginal Antifungal

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breastfeeding , ask a health professional before use.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Other Information 9 words ▾

If swallowed, call poison control or seek medical help.

📄 Package Label / Principal Display Panel 1 words ▾

Tube

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Clotrimazole (matched by generic name) — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Clotrimazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.43M
Claims incl. refills
276K
Beneficiaries
207.9K
Spend / beneficiary
$30.91
Spend / claim
$23.28
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for femmesil Ultra Therapy (this brand).

Top reported reactions

Macular Degeneration812
Nausea811
Pain777
Headache735
Dyspnoea705
Fatigue640
Diarrhoea598

Age at onset

Neonate46
Infant16
Child33
Adolescent23
Adult1,078
Elderly891

Reporter sex

11,489 reports
Male · 34%
Female · 65%
Unknown · 0%

Serious outcomes

Hospitalization3,953
Death924
Life-threatening676
Disabling393
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1,034 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aidance Scientific, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Aidance Scientific, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 24909-0049-01 · Aidance 24909-0051-14 · Aidance →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.